نتائج البحث

11

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

المؤلفون: Marek Kovar, Lorenzo Galluzzi, Jana Rakova, Justin Kline, Jitka Fucikova, Peter Holicek, Josef Pasulka, Monika Holubova, Iva Truxova, Zdenek Racil, Radek Spisek, Daniel Lysák, Cyril Salek, Michal Hensler, Lenka Kasikova

المصدر: Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)

مصطلحات موضوعية: 0301 basic medicine, lag-3, Immunology, innate lymphoid cells, CD8-Positive T-Lymphocytes, HAVCR2, 03 medical and health sciences, 0302 clinical medicine, Immune system, TIGIT, hemic and lymphatic diseases, tigit, Immunology and Allergy, Medicine, Cytotoxic T cell, Humans, Co-inhibitory receptor, Hepatitis A Virus Cellular Receptor 2, RC254-282, Original Research, business.industry, Innate lymphoid cell, Myeloid leukemia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC581-607, Killer Cells, Natural, CTL, Leukemia, Myeloid, Acute, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, vista, Immunologic diseases. Allergy, business, CD8, T-Lymphocytes, Cytotoxic, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c219a2ae8bc43638000406a3d711f16Test
https://pubmed.ncbi.nlm.nih.gov/33758676Test

12

Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3

المؤلفون: Xuan Zeng, Xiaohua Shi, Yuanyuan Liu, Shafei Wu, Feng Mao, Yufeng Luo, Xuefei Wang, Jing Wang

المصدر: Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)

مصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, PD-L1, 0301 basic medicine, Population, Immunology, Gene Expression, Triple Negative Breast Neoplasms, DNA Mismatch Repair, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, LAG-3, Antigens, CD, medicine, Humans, Immunology and Allergy, education, In Situ Hybridization, Fluorescence, Triple-negative breast cancer, Original Research, Aged, Mismatch Repair Endonuclease PMS2, Retrospective Studies, education.field_of_study, Predictive marker, biology, business.industry, Microsatellite instability, CD8, Middle Aged, medicine.disease, Immunohistochemistry, Lymphocyte Activation Gene 3 Protein, DNA-Binding Proteins, MutS Homolog 2 Protein, 030104 developmental biology, 030220 oncology & carcinogenesis, triple-negative breast cancer, Cancer research, biology.protein, Female, Microsatellite Instability, DNA mismatch repair, lcsh:RC581-607, MutL Protein Homolog 1, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f8638be7b5d5c3455a7f2a20b9865dTest

13

FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer

المؤلفون: Anna-Lena Ohlson, Jennifer R. Rider, Ove Andrén, Sabina Davidsson, Jessica Carlsson, Michelangelo Fiorentino, Francesca Giunchi, Swen-Olof Andersson

المساهمون: Davidsson, Sabina, Andren, Ove, Ohlson, Anna-Lena, Carlsson, Jessica, Andersson, Swen-Olof, Giunchi, Francesca, Rider, Jennifer R., Fiorentino, Michelangelo

المصدر: The Prostate

مصطلحات موضوعية: 0301 basic medicine, PCA3, Male, Pathology, medicine.medical_specialty, Urology, Lag-3+Treg, chemical and pharmacologic phenomena, T-Lymphocytes, Regulatory, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Immune system, Prostate, medicine, CD4+FOXP3+ Tregs, Humans, Prostatectomy, Prostatic Intraepithelial Neoplasia, Intraepithelial neoplasia, business.industry, FOXP3, Prostatic Neoplasms, Forkhead Transcription Factors, Forkhead Transcription Factor, Original Articles, Hyperplasia, medicine.disease, Lag‐3+ Tregs, 030104 developmental biology, medicine.anatomical_structure, Oncology, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, prostate carcinoma, Prostatic Neoplasm, Urinary Bladder Neoplasm, Original Article, business, Infiltration (medical), CD4+FOXP3+Treg, Human

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d020558f8a64c48434dfcfa5705d60f3Test
http://europepmc.org/articles/PMC5725695Test

14

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma

المؤلفون: Hong Chang, Pallavi Galera, Andrew M. Evens, Vladislav V. Makarenko, Ravi Dashnamoorthy, Srimoyee Ghosh, Benjamin J. Chen

المصدر: Oncotarget
Scopus-Elsevier

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691259913c941e373e7014eb11a37fd9Test
http://europepmc.org/articles/PMC6459346Test

15

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

المؤلفون: Mahmut Muslumanoglu, Yesim Eralp, Abdullah Igci, Pinar Saip, Adnan Aydiner, Hüseyin Karatay, Semen Onder, Neslihan Cabioglu, Gizem Oner, Mustafa Tukenmez, Vahit Ozmen, Ekrem Yavuz

المصدر: BMC cancer
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, LAG3, medicine.medical_treatment, Locally advanced, Triple Negative Breast Neoplasms, lcsh:RC254-282, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Breast cancer, Lymphocytes, Tumor-Infiltrating, Surgical oncology, LAG-3, Internal medicine, PDL1, Genetics, Medicine, Humans, In patient, Triple negative breast cancer, Hepatitis A Virus Cellular Receptor 2, T-cell immunoglobulin, Triple-negative breast cancer, Aged, CTLA4, Chemotherapy, Mucin domain-containing molecule 3 (TIM3), business.industry, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immune checkpoint, Neoadjuvant Therapy, PD1, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Tumor infiltrating lymphocytes (TILs), Human medicine, business, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2bb120ae9ed5d1ca228f19d5158223aTest
https://repository.uantwerpen.be/docstore/d:irua:6340Test

16

LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma—Potential Biomarkers for Targeted Therapy Concepts

المؤلفون: Stefan Gattenlöhner, Alexander Quaas, Nora Wuerdemann, Reinhard Büttner, Rishabh Jain, Steffen Wagner, Jens Peter Klussmann, Hans Edmund Eckel, Christian U. Huebbers, Katharina Pütz, Shachi Jenny Sharma, Christine Langer, Ernst-Jan M. Speel, Malte Suchan, Claus Wittekindt

المساهمون: RS: GROW - R2 - Basic and Translational Cancer Biology, Pathologie

المصدر: International Journal of Molecular Sciences
Volume 22
Issue 1
International Journal of Molecular Sciences, 22(1):379. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, Vol 22, Iss 379, p 379 (2021)

مصطلحات موضوعية: 0301 basic medicine, Male, B7 Antigens, medicine.medical_treatment, VISTA, Targeted therapy, lcsh:Chemistry, 0302 clinical medicine, Molecular Targeted Therapy, human papillomavirus, lcsh:QH301-705.5, Hepatitis A Virus Cellular Receptor 2, Spectroscopy, Tissue microarray, General Medicine, Middle Aged, Prognosis, Lymphocyte Activation Gene 3 Protein, Computer Science Applications, Gene Expression Regulation, Neoplastic, Survival Rate, Oropharyngeal Neoplasms, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, CD8-positive T-lymphocytes, Female, T cell, TIM-3, Catalysis, Article, Inorganic Chemistry, 03 medical and health sciences, Immune system, Lymphocytes, Tumor-Infiltrating, Antigens, CD, LAG-3, medicine, Biomarkers, Tumor, Humans, tumor microenvironment, Physical and Theoretical Chemistry, Molecular Biology, Tumor microenvironment, Tumor-infiltrating lymphocytes, business.industry, Organic Chemistry, Immune checkpoint, 030104 developmental biology, lcsh:Biology (General), lcsh:QD1-999, Case-Control Studies, Cancer research, oropharyngeal squamous cell carcinoma, business, CD8, Follow-Up Studies